{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:30:36Z","timestamp":1792683036996,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001170","name":"Cancer Council Western Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2016596"],"award-info":[{"award-number":["2016596"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031198","name":"Department of Health, Government of Western Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000951","name":"Cancer Council Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000951","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021840","name":"i-Care Foundation Pakistan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021840","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001169","name":"Cancer Council Tasmania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001169","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular & Cellular Proteomics"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.mcpro.2025.100925","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T19:12:38Z","timestamp":1738782758000},"page":"100925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Multiple Classes of Antigen Contribute to the Antigenic Landscape of Mesothelioma"],"prefix":"10.1016","volume":"24","author":[{"given":"Kirti","family":"Pandey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pouya","family":"Faridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.C. Gary","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebony","family":"Rouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay S.G.","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec","family":"Redwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9391-9395","authenticated-orcid":false,"given":"Jenette","family":"Creaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0532-8331","authenticated-orcid":false,"given":"Anthony W.","family":"Purcell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcpro.2025.100925_bib1","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jtho.2023.01.095","article-title":"Global incidence, risk factors, and temporal trends of mesothelioma: a population-based study","volume":"18","author":"Huang","year":"2023","journal-title":"J.\u00a0Thorac. Oncol."},{"key":"10.1016\/j.mcpro.2025.100925_bib2","doi-asserted-by":"crossref","first-page":"e2120360","DOI":"10.1001\/jamanetworkopen.2021.20360","article-title":"Assessment of global trends in the diagnosis of mesothelioma from 1990 to 2017","volume":"4","author":"Zhai","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.mcpro.2025.100925_bib3","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.21037\/tlcr.2019.11.11","article-title":"Epidemiology of mesothelioma in the 21(st) century in Europe and the United States, 40 years after restricted\/banned asbestos use","volume":"9","author":"Alpert","year":"2020","journal-title":"Translational Lung Cancer Res."},{"key":"10.1016\/j.mcpro.2025.100925_bib4","series-title":"Mesothelioma in Australia 2021","year":"2023"},{"key":"10.1016\/j.mcpro.2025.100925_bib5","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.3390\/cancers15112940","article-title":"Success of checkpoint blockade paves the way for novel immune therapy in malignant pleural mesothelioma","volume":"15","author":"Rondon","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mcpro.2025.100925_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.25109","article-title":"Prevalence of high tumor mutational burden and association with survival in patients with less common solid tumors","volume":"3","author":"Shao","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.mcpro.2025.100925_bib7","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.3389\/fimmu.2018.02039","article-title":"Human endogenous retroviruses are ancient acquired elements still shaping innate immune responses","volume":"9","author":"Grandi","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mcpro.2025.100925_bib8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10038-006-0370-0","article-title":"Ancient retroviral insertions among human populations","volume":"51","author":"Herrera","year":"2006","journal-title":"J.\u00a0Hum. Genet."},{"key":"10.1016\/j.mcpro.2025.100925_bib9","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1101\/gr.248922.119","article-title":"LTR retroelement expansion of the human cancer transcriptome and immunopeptidome revealed by de novo transcript assembly","volume":"29","author":"Attig","year":"2019","journal-title":"Genome Res."},{"key":"10.1016\/j.mcpro.2025.100925_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.canlet.2021.03.004","article-title":"Endogenous retrovirus expression activates type-I interferon signaling in an experimental mouse model of mesothelioma development","volume":"507","author":"Sun","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mcpro.2025.100925_bib11","article-title":"Viral mimicry response is associated with clinical outcome in pleural mesothelioma","volume":"3","author":"Sun","year":"2022","journal-title":"JTO Clin. Res. Rep."},{"key":"10.1016\/j.mcpro.2025.100925_bib12","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1684713","article-title":"Identification of a CD8+ T-cell response to a predicted neoantigen in malignant mesothelioma","volume":"9","author":"Sneddon","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.mcpro.2025.100925_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3233\/CBM-210280","article-title":"Profile of soluble factors in pleural effusions predict prognosis in mesothelioma","volume":"33","author":"Dick","year":"2022","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.mcpro.2025.100925_bib14","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/s41596-019-0133-y","article-title":"Mass spectrometry\u2013based identification of MHC-bound peptides for immunopeptidomics","volume":"14","author":"Purcell","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.mcpro.2025.100925_bib15","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1002\/cpz1.92","article-title":"Isolation of HLA bound peptides by immunoaffinity capture and identification by mass spectrometry","volume":"1","author":"Pandey","year":"2021","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.mcpro.2025.100925_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molimm.2020.04.008","article-title":"In-depth mining of the immunopeptidome of an acute myeloid leukemia cell line using complementary ligand enrichment and data acquisition strategies","volume":"123","author":"Pandey","year":"2020","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.mcpro.2025.100925_bib17","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/pmic.201100463","article-title":"Using iRT, a normalized retention time for more targeted measurement of peptides","volume":"12","author":"Escher","year":"2012","journal-title":"Proteomics"},{"key":"10.1016\/j.mcpro.2025.100925_bib18","article-title":"HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy","volume":"9","author":"Marcu","year":"2021","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.mcpro.2025.100925_bib19","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.010587","article-title":"PEAKS DB: de novo sequencing assisted database search for sensitive and accurate peptide identification","volume":"11","author":"Zhang","year":"2012","journal-title":"Mol. Cell. Proteomics : MCP"},{"key":"10.1016\/j.mcpro.2025.100925_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baw087","article-title":"gEVE: a genome-based endogenous viral element database provides comprehensive viral protein-coding sequences in mammalian genomes","volume":"2016","author":"Nakagawa","year":"2016","journal-title":"Database"},{"key":"10.1016\/j.mcpro.2025.100925_bib21","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/s41592-021-01184-6","article-title":"Universal Spectrum identifier for mass spectra","volume":"18","author":"Deutsch","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.mcpro.2025.100925_bib22","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/s41592-021-01301-5","article-title":"DeepLC can predict retention times for peptides that carry as-yet unseen modifications","volume":"18","author":"Bouwmeester","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.mcpro.2025.100925_bib23","first-page":"3360","article-title":"NetMHCpan-4.0: improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data","volume":"199","author":"Jurtz","year":"2017","journal-title":"J.\u00a0Immunol. (Baltimore, Md. : 1950)"},{"key":"10.1016\/j.mcpro.2025.100925_bib24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cels.2020.06.010","article-title":"MHCflurry 2.0: improved pan-allele prediction of MHC class I-presented peptides by incorporating antigen processing","volume":"11","author":"O\u2019Donnell","year":"2020","journal-title":"Cell Syst."},{"key":"10.1016\/j.mcpro.2025.100925_bib25","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nmeth1109-786","article-title":"Improved visualization of protein consensus sequences by iceLogo","volume":"6","author":"Colaert","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1016\/j.mcpro.2025.100925_bib26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41587-022-01464-2","article-title":"Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors","volume":"41","author":"Kacen","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mcpro.2025.100925_bib27","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1074\/mcp.RA119.001846","article-title":"Immunopeptidomic analysis reveals that deamidated HLA-bound peptides arise predominantly from deglycosylated precursors","volume":"19","author":"Mei","year":"2020","journal-title":"Mol. Cell. Proteomics : MCP"},{"key":"10.1016\/j.mcpro.2025.100925_bib28","doi-asserted-by":"crossref","first-page":"5660","DOI":"10.1038\/s41467-020-19464-8","article-title":"Human endogenous retroviruses form a reservoir of T cell targets in hematological cancers","volume":"11","author":"Saini","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mcpro.2025.100925_bib29","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/1471-2164-9-376","article-title":"Novel functional view of the crocidolite asbestos-treated A549 human lung epithelial transcriptome reveals an intricate network of pathways with opposing functions","volume":"9","author":"Hevel","year":"2008","journal-title":"BMC Genomics"},{"key":"10.1016\/j.mcpro.2025.100925_bib30","doi-asserted-by":"crossref","first-page":"916839","DOI":"10.3389\/fonc.2022.916839","article-title":"Novel insights into mesothelioma therapy: emerging avenues and future prospects","volume":"12","author":"Kuryk","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mcpro.2025.100925_bib31","article-title":"Multiple therapeutic pathways in malignant mesothelioma identified by genomic mapping","author":"N\u0103stase","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.mcpro.2025.100925_bib32","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1158\/1055-9965.EPI-20-0083","article-title":"Mesothelioma biomarkers: a review highlighting contributions from the early detection research network","volume":"29","author":"Pass","year":"2020","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.mcpro.2025.100925_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.21873\/cgp.20023","article-title":"A\u00a0proteomic analysis of the malignant mesothelioma secretome using iTRAQ","volume":"14","author":"Creaney","year":"2017","journal-title":"Cancer genomics & proteomics"},{"key":"10.1016\/j.mcpro.2025.100925_bib34","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/bjc.2015.470","article-title":"A\u00a0proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma","volume":"114","author":"Kao","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mcpro.2025.100925_bib35","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1183\/09031936.00160210","article-title":"Recognition of pleural mesothelioma by mucin-1(950\u2013958)\/human leukocyte antigen A\u22170201-specific CD8+ T-cells","volume":"38","author":"Roulois","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.mcpro.2025.100925_bib36","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s00262-010-0881-6","article-title":"CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection","volume":"59","author":"Yamada","year":"2010","journal-title":"Cancer Immunol. Immunother. : CII"},{"key":"10.1016\/j.mcpro.2025.100925_bib37","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/leu.2014.233","article-title":"Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy","volume":"29","author":"Berlin","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.mcpro.2025.100925_bib38","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00401-018-1836-9","article-title":"The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy","volume":"135","author":"Neidert","year":"2018","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.mcpro.2025.100925_bib39","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1164\/rccm.200312-1683OC","article-title":"Cytotoxic T cell responses against mesothelioma by apoptotic cell-pulsed dendritic cells","volume":"169","author":"Ebstein","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.mcpro.2025.100925_bib40","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0264-410X(02)00600-X","article-title":"Anti-cancer therapy using dendritic cells and apoptotic tumour cells: pre-clinical data in human mesothelioma and acute myeloid leukaemia","volume":"21","author":"Gr\u00e9goire","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.mcpro.2025.100925_bib41","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1158\/1078-0432.CCR-05-0596","article-title":"Identification of novel human CTL epitopes and their agonist epitopes of mesothelin","volume":"11","author":"Yokokawa","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mcpro.2025.100925_bib42","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.1158\/1078-0432.CCR-07-0708","article-title":"Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells","volume":"13","author":"May","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mcpro.2025.100925_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.645770","article-title":"IFN\u03b3 modulates the immunopeptidome of triple negative breast cancer cells by enhancing and diversifying antigen processing and presentation","volume":"12","author":"Goncalves","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mcpro.2025.100925_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41591-018-0302-5","article-title":"Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss","volume":"25","author":"Liu","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.mcpro.2025.100925_bib45","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/cdd.2015.165","article-title":"Molecular profiling reveals primary mesothelioma cell lines recapitulate human disease","volume":"23","author":"Chernova","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.mcpro.2025.100925_bib46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fimmu.2019.00141","article-title":"Pro-inflammatory cytokines alter the immunopeptidome landscape by modulation of HLA-B expression","volume":"10","author":"Javitt","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mcpro.2025.100925_bib47","doi-asserted-by":"crossref","first-page":"7056","DOI":"10.1038\/s41467-023-42668-7","article-title":"Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors","volume":"14","author":"Chiaro","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mcpro.2025.100925_bib48","article-title":"Soluble HLA peptidome of pleural effusions is a valuable source for tumor antigens","volume":"10","author":"Khazan-Kost","year":"2022","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.mcpro.2025.100925_bib49","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.3390\/cancers13163932","article-title":"Hitting the bull's-eye: mesothelin's role as a biomarker and therapeutic target for malignant pleural mesothelioma","volume":"13","author":"Yeo","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.mcpro.2025.100925_bib50","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.mcpro.2025.100925_bib51","doi-asserted-by":"crossref","first-page":"997919","DOI":"10.3389\/fonc.2022.997919","article-title":"The versatile utility of cysteine as a target for cancer treatment","volume":"12","author":"Min","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mcpro.2025.100925_bib52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","article-title":"Neoantigens: promising targets for cancer therapy","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduction Targeted Ther."},{"key":"10.1016\/j.mcpro.2025.100925_bib53","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.3390\/jcm10112470","article-title":"Molecular fingerprints of malignant pleural mesothelioma: not just a matter of genetic alterations","volume":"10","author":"Lorenzini","year":"2021","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.mcpro.2025.100925_bib54","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.4049\/jimmunol.166.7.4543","article-title":"Cysteinylation of MHC class II ligands: peptide endocytosis and reduction within APC influences T cell Recognition1","volume":"166","author":"Haque","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.mcpro.2025.100925_bib55","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1084\/jem.189.11.1757","article-title":"Modification of cysteine residues in\u00a0vitro and in\u00a0vivo affects the immunogenicity and antigenicity of major histocompatibility complex class I-restricted viral determinants","volume":"189","author":"Chen","year":"1999","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.mcpro.2025.100925_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj3671","article-title":"Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy","volume":"8","author":"Bonaventura","year":"2022","journal-title":"Sci. Adv."}],"container-title":["Molecular & Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947625000234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947625000234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:07:08Z","timestamp":1778818028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947625000234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1535947625000234"],"URL":"https:\/\/doi.org\/10.1016\/j.mcpro.2025.100925","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple Classes of Antigen Contribute to the Antigenic Landscape of Mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcpro.2025.100925","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"100925"}}